As of Feb 27
| +0.95 / +2.25%|
The 5 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 50.00, with a high estimate of 59.00 and a low estimate of 40.00. The median estimate represents a +16.06% increase from the last price of 43.08.
The current consensus among 5 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.